Page 524 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 524
4 References
84. Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and 98. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril
safety of tenecteplase in combination with the low-molecular- on mortality and morbidity in patients with left ventricular
weight heparin enoxaparin or unfractionated heparin in the dysfunction after myocardial infarction. Results of the Survival
prehospital setting: the Assessment of the Safety and Efficacy and Ventricular Enlargement Trial. N Engl J Med. 1992;327:
of a New Fibrinolytic Regimen (ASSENT)-3 PLUS random- 669-677.
ized trial in acute myocardial infarction. Circulation. 2003;108: 99. Edner M, Bonarjee VV, Nilsen DW, Berning J, Carstensen S,
135-142. Caidahl K. Effect of enalapril initiated early after acute
85. Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux myocardial infarction on heart failure parameters, with refer-
on mortality and reinfarction in patients with acute ST-segment ence to clinical class and echocardiographic determinants.
elevation myocardial infarction: the OASIS-6 randomized trial. CONSENSUS II Multi-Echo Study Group. Clin Cardiol. 1996;19:
JAMA. 2006;295:1519-1530. 543-548.
86. Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and 100. Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarc-
safety of fondaparinux versus enoxaparin in patients with tion in patients with non-Q-wave myocardial infarction. Results
acute coronary syndromes undergoing percutaneous coronary of a double-blind, randomized, multicenter trial. N Engl J Med.
intervention: results from the OASIS-5 trial. J Am Coll Cariol. 1986;315:423-429.
2007;50:1742-1751. 101. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of
87. Gruppo Italiano per lo Studio della Sopravvinza nell’Infarto prophylactic lidocaine in suspected acute myocardial infarction.
Miocardico (GISSI). GISSI-3: effects of lisinopril and transder- An overview of results from the randomized, controlled trials.
mal glyceryl trinitrate singly and together on 6-week mortality JAMA. 1988;260:1910-1916.
and ventricular function after acute myocardial infarction. 102. Lauler DP. Magnesium—coming of age. Am J Cardiol.
Lancet. 1994;343:1115-1122. 1989;63:1g-3g.
88. ISIS-4 (Fourth International Study of Infarct Survival) Study 103. Braunwald E. Unstable angina. A classification. Circulation.
Group. ISIS-4: a randomised factorial trial assessing early oral 1989;80:410-414.
captopril, oral mononitrate, and intravenous magnesium sul- 104. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac
phate in 58,050 patients with suspected acute myocardial infarc- troponin T levels for risk stratification in acute myocardial
tion. Lancet. 1995;345:669-685. ischemia. N Engl J Med. 1996;335:133-1341.
89. First International Study of Infarct Survival Collaborative 105. Lewis HD Jr, Davis JW, Archibald DG, et al. Protective effects
Group. Randomised trial of intravenous atenolol among 16 027 of aspirin against acute myocardial infarction and death in men
cases of suspected acute myocardial infarction: ISIS-1. Lancet. with unstable angina. Results of a Veterans Administration
1986;2:57-66. Cooperative Study. N Engl J Med. 1983;309:396-403.
90. TIMI Study Group. Comparison of invasive and conservative 106. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or
strategies after treatment with intravenous tissue plasminogen both in unstable angina. Results of a Canadian multicenter trial.
activator in acute myocardial infarction. Results of the throm- N Engl J Med. 1985;313:1369-1375.
bolysis in myocardial infarction (TIMI) phase II trial. N Engl J
Med. 1989;320:618-627. 107. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox
KK. Effects of clopidogrel in addition to aspirin in patients
91. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral with acute coronary syndromes without ST-segment elevation.
metoprolol in 45,852 patients with acute myocardial infarc- N Engl J Med. 2001;345:494-502.
tion: randomised placebo-controlled trial. Lancet. 2005;366:
1622-1632. 108. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment
with clopidogrel and aspirin followed by long-term therapy in
92. MIAMI Trial Research Group. Metoprolol in acute myocardial patients undergoing percutaneous coronary intervention: the
infarction (MIAMI). A randomised placebo-controlled interna- PCI-CURE study. Lancet. 2001;358:527-533.
tional trial. Eur Heart J. 1985;6:199-226. 109. Steinhubl SR, Berger PB, Mann JT III, et al. Early and sus-
93. The International Collaborative Study Group. Reduction of tained dual oral antiplatelet therapy following percutaneous
infarct size with the early use of timolol in acute myocardial coronary intervention: a randomized controlled trial. JAMA.
infarction. N Engl J Med. 1984;310:9-15. 2002;288:2411-2420.
94. Dargie HJ. Effect of carvedilol on outcome after myocardial 110. CAPRIE Steering Committee. A randomised, blinded, trial of
infarction in patients with left-ventricular dysfunction: the clopidogrel versus aspirin in patients at risk of ischaemic events
CAPRICORN randomised trial. Lancet. 2001;357:1385-1390. (CAPRIE). Lancet. 1996;348:1329-1339.
95. CONSENSUS Trial Study Group. Effects of enalapril on mortal- 111. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopi-
ity in severe congestive heart failure. Results of the Cooperative dogrel in patients with acute coronary syndromes. N Engl J Med.
North Scandinavian Enalapril Survival Study (CONSENSUS). 2009;361:1045-1057.
N Engl J Med. 1987;316:1429-1435. 112. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA
96. SOLVD Investigators. Effect of enalapril on survival in patients 2007 guidelines for the management of patients with unstable
with reduced left ventricular ejection fractions and congestive angina/non ST-elevation myocardial infarction: a report of the
heart failure. N Engl J Med. 1991;325:293-302. American College of Cardiology/American Heart Association
97. SOLVD Investigators. Effect of enalapril on mortality and Task Force on Practice Guidelines. J Am Coll Cardiol.
the development of heart failure in asymptomatic patients 2007;116:803-877.
with reduced left ventricular ejection fractions. N Engl J Med. 113. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both
1992;327:685-691. to treat acute unstable angina. N Engl J Med. 1988;319:1105-1111.
Section03-O-ref.indd 4 1/20/2015 7:10:23 AM

